A novel study design for the comparison between once-daily QVA149 and twice-daily salmeterol/fluticasone on the reduction of COPD exacerbations: The FLAME study

被引:0
|
作者
Wedzicha, Jadwiga A. [1 ]
Decramer, Marc [2 ]
Vestbo, Jorgen [3 ]
Gallagher, Nicola [4 ]
Kim, Han-Joo [5 ]
McBryan, Danny [6 ]
Banerji, Donald [5 ]
机构
[1] UCL, Dept Acad Resp Med, London, England
[2] Univ Leuven, Univ Hosp, Div Resp, Leuven, Belgium
[3] Manchester Acad Hlth Sci Ctr, Resp Res Grp, Manchester, Lancs, England
[4] Novartis Horsham Res Ctr, Primary Care, Horsham, W Sussex, England
[5] Novartis Pharmaceut, Primary Care, E Hanover, NJ USA
[6] Novartis Pharma AG, Primary Care, Basel, Switzerland
关键词
COPD; -; management; Bronchodilators; Exacerbation;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2208
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
    Kornmann, O.
    Dahl, R.
    Centanni, S.
    Dogra, A.
    Owen, R.
    Lassen, C.
    Kramer, B.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 273 - 279
  • [22] Once-daily QVA149 has a good safety profile in patients with COPD
    Welte, Tobias
    Vogelmeier, Claus
    Dahl, Ronald
    Chapman, Kenneth R.
    Rudolf, Michael
    Mehta, Rajendra
    D'Andrea, Peter
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [23] Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
    Buhl, Roland
    Gessner, Christian
    Schuermann, Wolfgang
    Foerster, Karin
    Sieder, Christian
    Hiltl, Simone
    Korn, Stephanie
    THORAX, 2015, 70 (04) : 311 - +
  • [24] Dual Bronchodilation With Once-Daily Qva149 Significantly Improves Lung Function Versus Single Bronchodilators And Salmeterol/fluticasone
    Bateman, E. D.
    Ferguson, G. T.
    Welte, T.
    D'Andrea, P.
    Alagappan, V.
    Chen, H.
    Green, Y.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [25] REDUCTION IN THE RATE AND RISK OF MODERATE OR SEVERE EXACERBATIONS WITH ONCE-DAILY INDACATEROL/GLYCOPYRRONIUM COMPARED WITH TWICE-DAILY SALMETEROL/FLUTICASONE IN A SUBSET OF GOLD GROUP D COPD PATIENTS WITH A HISTORY OF ≥2 EXACERBATIONS OR 1 HOSPITALIZATION: THE FLAME STUDY
    Banerji, D.
    Vogelmeier, C.
    Wedzicha, J.
    Donohue, J.
    Fucile, S.
    Yadao, A.
    Ayers, T.
    Thach, C.
    Olsson, P.
    Fowlertaylor, A.
    Fogel, R.
    Patalano, F.
    RESPIROLOGY, 2018, 23 : 74 - 74
  • [26] Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
    Korn, Stephanie
    Kerwin, Edward
    Atis, Sibel
    Amos, Carolynn
    Owen, Roger
    Lassen, Cheryl
    RESPIRATORY MEDICINE, 2011, 105 (05) : 719 - 726
  • [27] Qva149 Once Daily Is Safe And Well Tolerated In Patients With COPD: The Shine Study
    Welte, T.
    Barnes, N.
    Nagase, T.
    Gallagher, N.
    Green, Y.
    Horton, R.
    Henley, M.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [28] Qva149 Once Daily Is Safe And Well Tolerated In Patients With COPD: The Illuminate Study
    Vogelmeier, C.
    Bateman, E. D.
    Pallante, J.
    Bryant, H.
    Alagappan, V.
    D'Andrea, P.
    Chen, H.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [29] EFFICACY AND SAFETY OF ONCE-DAILY INDACATEROL/MOMETASONE COMPARED WITH TWICE-DAILY SALMETEROL/FLUTICASONE IN PATIENTS WITH MODERATE TO VERY SEVERE COPD
    Kirsten, Anne-Maria
    Richard, Alexia
    Tanase, Ana-Maria
    Cao Weihua
    Hosoe, Motoi
    Hederer, Bettina
    THORAX, 2014, 69 : A187 - A187
  • [30] Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials
    Banerji, Donald
    Alagappan, Vijay
    Green, Yulia
    Gallagher, Nicola
    FowlerTaylor, Angel
    D'Andrea, Peter
    Chen, Hungta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42